Domov › Srčno popuščanje › Kalifornija › San Francisco
Klinične študije za Srčno popuščanje v San Francisco, CA
29 študij za Srčno popuščanje išče udeležence na lokacijah v San Francisco in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
ELEVATE-HFpEF Clinical Study
Vključevanje udeležencev
- Sutter Health Hospital, San Francisco
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Vključevanje udeležencevFaza 3
- Research Site, San Francisco
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
Vključevanje udeležencevFaza 2
- University of California, San Francisco, San Francisco
- University of California San Francisco UCSF, San Francisco
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Vključevanje udeležencevFaza 3
- California Pacific Medical Center Van Ness Campus, San Francisco
Alleviant ALLAY-HFrEF Study
Vključevanje udeležencev
- University of California San Francisco, San Francisco
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Vključevanje udeležencevFaza 3
- Kaiser Permanente, San Francisco
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Vključevanje udeležencevFaza 3
- Research Site, San Francisco
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Vključevanje udeležencevFaza 3
- San Francisco, CA Investigative Site CON-10315, San Francisco
- CON-10023, San Francisco, CA, San Francisco
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Vključevanje udeležencevFaza 3
- San Francisco, CA Investigative Site 10023, San Francisco
Remote Dielectric Sensing (ReDS) Assisted Diuresis in Acute Decompensated Heart Failure
Vključevanje udeležencev
- University of California, San Francisco, San Francisco
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
Vključevanje udeležencevFaza 2
- University of California, San Francisco - Heart and Vascular Center, San Francisco
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Vključevanje udeležencev
- Zuckerberg San Francisco General, San Francisco
- University of California San Francisco, San Francisco
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
Vključevanje udeležencevOpazovalna študija
- University Of California San Francisco Medical Center, San Francisco
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Vključevanje udeležencevFaza 3
- Tenax Investigational Site, San Francisco
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Vključevanje udeležencevFaza 3
- Kaiser Permanente Northern California, San Francisco
- San Francisco V.A. Medical Center, San Francisco
Alleviant ALLAY-HF Study
Vključevanje udeležencev
- University of California San Francisco, San Francisco
Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
Vključevanje udeležencevFaza 3
- UC San Francisco Medical Center, San Francisco
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
Vključevanje udeležencevFaza 3
- San Francisco, CA Investigative Site FIN-10023, San Francisco
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Vključevanje udeležencev
- UCSF Medical Center, San Francisco
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Vključevanje udeležencev
- University of California at San Francisco, San Francisco
Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
Vključevanje udeležencevFaza 3
- UC San Francisco Medical Center, San Francisco
- UC San Francisco Medical Center, San Francisco
Developing a Digital Aid to Improve ICD Decisions
Vključevanje udeležencev
- University of California, San Francisco, San Francisco
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Vključevanje udeležencev
- University of California- San Francisco, San Francisco
Voice Analysis to Detect Pulmonary Arterial Pressure Changes in Heart Failure
Vključevanje udeležencevOpazovalna študija
- University of California, San Francisco (UCSF), San Francisco
Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future
Vključevanje udeležencevOpazovalna študija
- UCSF, San Francisco
AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM
Vključevanje udeležencevOpazovalna študija
- University of California, San Francisco, San Francisco
- Kaiser Permanente San Francisco, San Francisco
Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVC
Vključevanje udeležencevFaza 1
- University of California San Francisco, San Francisco
Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
Vključevanje udeležencevOpazovalna študija
- University of California San Francisco, San Francisco
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Vključevanje udeležencevFaza 1/2
- University of California, San Francisco, San Francisco
Študije za Srčno popuščanje v drugih mestih
- New York City, NY51 študij
- Boston, MA44 študij
- Dallas, TX42 študij
- Houston, TX36 študij
- Cleveland, OH33 študij
- Chicago, IL31 študij
- Philadelphia, PA31 študij
- St. Louis, MO26 študij
- Durham, NC26 študij
- Atlanta, GA25 študij
- Kansas City, MO25 študij
- Baltimore, MD24 študij
Druge študije v San Francisco
- Rak prostate45 študij
- Rak dojke43 študij
- Nemalicelični pljučni rak36 študij
- Rak (vse vrste)35 študij
- Metastatski rak28 študij
- Rak pljuč23 študij
- Melanom22 študij
- Rak trebušne slinavke20 študij
- Rak jajčnikov19 študij
- Kolorektalni rak18 študij
- Srčno-žilne bolezni18 študij
- Glioblastom17 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.